KaloBios to Stop KB003 Development for Asthma – Analyst Blog
KaloBios Pharmaceuticals, Inc. ( KBIO ) announced disappointing top line results from a phase II study on KB003 in patients …read more
KaloBios Pharmaceuticals, Inc. ( KBIO ) announced disappointing top line results from a phase II study on KB003 in patients …read more
Omeros Corporation ( OMER ) announced positive results from a phase IIa study on OMS824, being evaluated for the …read more
Oil refiner and marketer Western Refining Inc. ( WNR ) has increased its quarterly cash dividend for the first quarter …read more
Natural gas pipeline operator, Energy Transfer Partners LP ( ETP ) raised its fourth quarter 2013 cash distribution to 92 …read more
JDS Uniphase ( JDSU ), a leading provider of communications test and measurement solutions, is slated to report its second …read more
By Pring Turner In March 2009, the S&P 500 reached its lowest point since the turn of the 21st century. …read more
In its noble endeavor to enable people attain long lasting health and overall wellness, Essence Healthcare announced renewal of its …read more
A few years ago, as Crude Oil climbed to all time highs, investors were turned on to an obscure index …read more
We expect property and casualty insurer The Chubb Corp. ( CB ) to beat expectations when it reports fourth quarter …read more
Southwest Airlines Co. ( LUV ) will fly beyond national boundaries to three destinations in the Caribbean Island from Jul …read more